SR 49059

Known as: SR-49059, SR49059 
 

Topic mentions per year

Topic mentions per year

1995-2018
0519952018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
The mechanisms by which arginine vasopressin (AVP) exerts its antidiuretic and pressor effects, via activation of V2 and V1a… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
In many mendelian diseases, some mutations result in the synthesis of misfolded proteins that cannot reach a transport-competent… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2006
2006
The hypothalamus coordinates autonomic responses in part through arginine vasopressin (AVP) released in medial nucleus tractus… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2004
2004
Vasopressin receptor subtype(s) responsible for stimulation of insulin release from pancreatic beta cells were investigated by… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • figure 3
Is this relevant?
2004
2004
In most cases, nephrogenic diabetes insipidus results from mutations in the V2 vasopressin receptor (V2R) gene that cause… (More)
Is this relevant?
2004
2004
BACKGROUND Compounds that block uterine oxytocin and vasopressin V1a receptors have a therapeutic potential in preterm labor and… (More)
  • table I
  • figure 1
  • figure 2
  • table II
  • table III
Is this relevant?
2003
2003
Magnocellular neurons of the supraoptic nucleus release the neuropeptides oxytocin and vasopressin from their dendrites to… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1999
1999
OBJECTIVE The present study was undertaken to examine whether arginine vasopressin (AVP) relaxes primate coronary artery and to… (More)
Is this relevant?
1999
1999
A potent non-peptide vasopressin (AVP) antagonist, SR-49059, displaying high stability and selective affinity for the V1a AVP… (More)
Is this relevant?
1995
1995
The effects of SR-49059, a new nonpeptide and selective arginine vasopressin (AVP) V1a antagonist, were investigated in binding… (More)
Is this relevant?